Mohammad S. Alavijeh
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 4
- Electrospun Nanofibers in Biomedical Applications 4
- Pharmaceutical Science top 5%
-
- Neuroscience and Neuropharmacology Research 4
- Neurology top 10%
- Pharmacology top 10%
-
- Research on Leishmaniasis Studies 6
-
- Epilepsy research and treatment 6
-
- Pharmacological Effects and Toxicity Studies 6
-
- SARS-CoV-2 and COVID-19 Research 4
-
- Trypanosoma species research and implications 4
- Co-authors
- Alan M. PalmerMansoor ChishtyAlexander M. SeifalianPhilip N. PatsalosEmily FowlerHazel JonesChristopher R. IresonYasmin Farhatnia
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- United KingdomIranUnited States
In The Last Decade
Mohammad S. Alavijeh
48 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 129
- Biomaterials 219
- Pharmaceutical Science 83
- Cellular and Molecular Neuroscience 233
- Neurology 84
- Pharmacology 133
Countries citing papers authored by Mohammad S. Alavijeh
This map shows the geographic impact of Mohammad S. Alavijeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad S. Alavijeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad S. Alavijeh more than expected).
Fields of papers citing papers by Mohammad S. Alavijeh
This network shows the impact of papers produced by Mohammad S. Alavijeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad S. Alavijeh. The network helps show where Mohammad S. Alavijeh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad S. Alavijeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 15 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 29 | |
| 6 | 2019 | 138 | |
| 7 | 2018 | 37 | |
| 8 | 2017 | 12 | |
| 9 | 2014 | 10 | |
| 10 | 2014 | 13 | |
| 11 | 2012 | 64 | |
| 12 | 2012 | 35 | |
| 13 | 2011 | 21 | |
| 14 | 2010 | 7 | |
| 15 | Feature on Advances in Drug Discovery: Population Aging: A Challenge for CNS Drug Discovery | 2005 | 1 |
| 16 | Feature on Advances in Drug Discovery 高齢化:中枢神経系医薬品創製へのチャレンジ | 2005 | 1 |
| 17 | 2001 | 33 | |
| 18 | 2000 | 57 | |
| 19 | 1996 | 34 | |
| 20 | 1995 | 21 |
About Mohammad S. Alavijeh
Mohammad S. Alavijeh is a scholar working on Biomaterials, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (6 papers), Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Trypanosoma species research and implications (4 papers), Neuroscience and Neuropharmacology Research (4 papers) and Electrospun Nanofibers in Biomedical Applications (4 papers). The work is most often cited by research in Biomaterials (219 citations), Pharmaceutical Science (83 citations) and Cellular and Molecular Neuroscience (233 citations). Mohammad S. Alavijeh has collaborated with scholars based in United Kingdom, Iran and United States. Frequent co-authors include Alan M. Palmer, Mansoor Chishty, Alexander M. Seifalian, Philip N. Patsalos, Emily Fowler, Hazel Jones, Christopher R. Ireson, Yasmin Farhatnia, Aaron Tan and Matthew C. Walker. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.